Spondylarthropathies D025242

Diseases [C] » Musculoskeletal Diseases [C05] » Bone Diseases » Spinal Diseases » Spondylitis » Spondylarthritis » Spondylarthropathies

Diseases [C] » Musculoskeletal Diseases [C05] » Joint Diseases » Arthritis » Spondylarthritis » Spondylarthropathies

Description

Heterogeneous group of arthritic diseases sharing clinical and radiologic features. They are associated with the HLA-B27 ANTIGEN and some with a triggering infection. Most involve the axial joints in the SPINE, particularly the SACROILIAC JOINT, but can also involve asymmetric peripheral joints. Subsets include ANKYLOSING SPONDYLITIS; REACTIVE ARTHRITIS; PSORIATIC ARTHRITIS; and others.   MeSH

Subtype Terms (3)

Arthritis, Psoriatic
74 drugs (50 approved, 24 experimental)

Arthritis, Reactive
12 drugs (7 approved, 5 experimental)

Axial Spondyloarthritis
34 drugs (25 approved, 9 experimental)


Approved Indicated Drugs (1)

Phase 2 Indicated Drugs (1)

Phase 1 Indicated Drugs (1)


Organization Involved with Phase 2 Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.